DE3343253C2 - - Google Patents

Info

Publication number
DE3343253C2
DE3343253C2 DE3343253A DE3343253A DE3343253C2 DE 3343253 C2 DE3343253 C2 DE 3343253C2 DE 3343253 A DE3343253 A DE 3343253A DE 3343253 A DE3343253 A DE 3343253A DE 3343253 C2 DE3343253 C2 DE 3343253C2
Authority
DE
Germany
Prior art keywords
parts
weight
fluoride
sugar
talc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3343253A
Other languages
German (de)
English (en)
Other versions
DE3343253A1 (de
Inventor
Neill Bailey San Antonio Tex. Us Walsdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mission Pharmacal Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3343253A1 publication Critical patent/DE3343253A1/de
Application granted granted Critical
Publication of DE3343253C2 publication Critical patent/DE3343253C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19833343253 1983-08-11 1983-11-30 Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung Granted DE3343253A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52201483A 1983-08-11 1983-08-11

Publications (2)

Publication Number Publication Date
DE3343253A1 DE3343253A1 (de) 1985-02-21
DE3343253C2 true DE3343253C2 (fr) 1989-07-20

Family

ID=24079076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833343253 Granted DE3343253A1 (de) 1983-08-11 1983-11-30 Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung

Country Status (4)

Country Link
JP (1) JPS6042323A (fr)
CA (1) CA1219219A (fr)
CH (1) CH655851A5 (fr)
DE (1) DE3343253A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3851776T2 (de) * 1987-04-28 1995-05-04 Boehringer Mannheim Gmbh Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
WO2004078164A1 (fr) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue
CN103439377B (zh) * 2013-08-13 2015-12-09 江苏大学 一种NaF释放的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
DE2630326C2 (de) * 1976-07-06 1983-07-21 "Gebro" G. Broschek Kg, Chemisch-Pharmazeutische Fabrik, 6391 Fieberbrunn, Tirol Präparat zur Behandlung der Osteoporose und seine Herstellung

Also Published As

Publication number Publication date
CH655851A5 (de) 1986-05-30
DE3343253A1 (de) 1985-02-21
JPH0130807B2 (fr) 1989-06-22
CA1219219A (fr) 1987-03-17
JPS6042323A (ja) 1985-03-06

Similar Documents

Publication Publication Date Title
EP0108898B1 (fr) Formes galéniques orales de mopidamol
DE69820287T2 (de) Pharmazeutische Zubereitung, die Chlodronat als Wirkstoff und silicifizierte mikrokristalline Cellulose als Exipienten umfasst
DE3880762T2 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE3879080T2 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE2808514A1 (de) Nitrofurantoin enthaltende tablette
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE60020501T3 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
LU84962A1 (de) Naproxen-und naproxen-natrium-tabletten mit kontrollierter wirkstoffreigabe
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
EP0068191A2 (fr) Formes orales du dipyridamole
EP2295083A1 (fr) Composition pharmaceutique renfermant les agents actifs metformine et sitagliptine ou vildagliptine
EP0625355B1 (fr) Comprimé à biodisponibilité améliorée contenant l'acide dichlorométhylène-diphosphonique en tant qu'ingrédient actif
EP0914823B1 (fr) Préparation orale à effet retard comprenant Tramadol et son procédé de fabrication
EP1928459B1 (fr) Preparation a liberation controlee sous forme de comprime contenant de la cinnarizine et du dimenhydrinate contre le vertige
EP0749304B9 (fr) Comprime a effet retard contenant du diclofenac-na
DE3727616A1 (de) Pharmazeutische zubereitung fuer die fluoridionen-versorgung
DE3733540A1 (de) Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes
EP3682870B1 (fr) Procédé de fabrication de comprimes faciles à prendre comprenant un extrait sec des feuilles de ginkgo biloba
CH655851A5 (de) Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung.
DE3117756C2 (fr)
DE3889259T2 (de) Trapidil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung.
DE69918163T2 (de) Ein profen enthaltende pharmazeutische mischung
DE2630326C2 (de) Präparat zur Behandlung der Osteoporose und seine Herstellung
DE69103724T2 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication of lapse of patent is to be deleted
8327 Change in the person/name/address of the patent owner

Owner name: MISSION PHARMACAL CO., SAN ANTONIO, TEX., US

8381 Inventor (new situation)

Inventor name: WALSDORF, NEILL BAILEY, SAN ANTONIO, TEX., US